Radiation therapy, chemotherapy and chemoradiation in hilar cholangiocarcinoma

HPB

Volumn 7, Issue 4, 2005, Pages 278-282

  Nakeeb, Attila ^a   Pitt, Henry A ^b,c  

^a INDIANA UNIVERSITY   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c Department of Surgery ^*  (United States)

Author keywords

Chemoradiation; Chemotherapy; Cholangiocarcinoma; Radiation therapy

Indexed keywords

ANISOLE DERIVATIVE; CISPLATIN; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; IRIDIUM 192; MESYLIC ACID DERIVATIVE; MITOMYCIN C; PACLITAXEL; RADIOSENSITIZING AGENT; RECOMBINANT ALPHA2B INTERFERON; RIFAMPICIN; SEMUSTINE; STREPTOZOCIN;

ASIA; BILE DUCT CARCINOMA; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; DRUG RESPONSE; EUROPE; HUMAN; INOPERABLE CANCER; KARNOFSKY PERFORMANCE STATUS; LIVER HILUS; LIVER RESECTION; MEDICAL LITERATURE; META ANALYSIS; PACIFIC ISLANDS; QUESTIONNAIRE; RADIOSENSITIZATION; RETROSPECTIVE STUDY; REVIEW; SURVIVAL TIME; SYSTEMATIC REVIEW; THERAPY EFFECT; UNITED STATES;

EID: 33745089310     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1080/13651820500373028     Document Type: Review

References (12)

1. Nakeeb, A and Pitt, H and Coleman, J and Hraban, R and Abrams, R and Cameron, J. (1996) Cholangiocarcinoma: A spectrum of intrahepatic, perihilar, and distal tumors Ann Surg, 224, pp. 463-75.
2. Nakeeb, A and Tran, K and Black, M and Ritch, P and Quebbeman, E and Wilson, S and (2002) Improved survival in resected biliary malignancies Surgery, 132, pp. 555-64.
3. Tsao, J and Nimura, Y and Kamija, J and Hayakowa, N and Kondo, S and Naqino, M and (2000) Management of hilar cholangiocarcinoma: Comparison of an American and Japanese experience Ann Surg, 232, pp. 166-74.
4. Jarnagin, W and Ruo, L and Little, S and Klimstra, D and D'Angelica, M and DeMatteo, R and (2003) Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies Cancer, 98, pp. 1689-700.
5. Todoroki, T and Ohara, K and Kawamoto, T and Koike, N and Yoshida, S and Kashiwagi, H and (2000) Benefits of adjuvant radiotherapy after radical resection of locally advanced main hepatic duct carcinoma Int J Radiat Oncol Biol Phys, 46, pp. 581-7.
6. Gerhards, M and van Gulik, T and Gonzalez Gonzalez, D and Rauws, E and Gouma, D. (2003) Results of postoperative radiotherapy for resectable hilar cholangiocarcinoma World J Surg, 27, pp. 173-9.
7. Pitt, H and Nakeeb, A and Abrams, R and Coleman, J and Piantadosi, S and Yeo, C and et al. (1995) Perihilar cholangiocarcinoma: Postoperative radiotherapy does not improve survival Ann Surg, 221, pp. 788-97.
8. Todoroki, T. (2000) Chemotherapy for bile duct carcinoma in the light of adjuvant chemotherapy to surgery Hepatogastroenterology, 47, pp. 644-9.
9. Falkson, G and MacIntyre, J and Moertel, C. (1984) Eastern Cooperative Oncology Group experience with chemotherapy for inoperable gallbladder and bile duct cancer Cancer, 54, pp. 965-9.
10. Patt, Y and Jones, D, Jr and Hoque, A and Lozano, R and Markowitz, A and Raijman, I and et al. (1996) Phase II trial of intravenous fluorouracil and subcutaneous interferon alfa-2b for biliary tract cancer J Clin Oncol, 14, pp. 2311-15.
11. Kim, S and Kim, S and Bang, Y and Heo, D and Ha, S. (2002) Role of postoperative radiotherapy in the management of extrahepatic bile duct cancer Int J Radiat Oncol Biol Phys, 54, pp. 414-19.
12. Pitt, H and Broelsch, C and Fong, Y and Gouma, D and Lau, J and Nagorney, D and (2003) Adjuvant therapy for biliary malignancies: international trends and possibilities J Gastrointest Surg, 7, pp. 309A.